What is the recommended evaluation and first-line treatment for typical absence seizures in an adult?

Absence Seizures in Adults

For typical absence seizures in adults, start with ethosuximide, valproic acid, or lamotrigine as first-line monotherapy, with valproic acid being particularly effective as it also controls other generalized seizure types that commonly coexist in adults. 1, 2

Evaluation

Clinical Assessment

• Document seizure characteristics: Brief episodes (seconds) of impaired consciousness with abrupt onset and termination
• Identify associated features: Look for subtle motor manifestations (eyelid myoclonia, perioral movements), automatisms, or autonomic symptoms
• Assess frequency and impact: Determine if absences are daily, weekly, or less frequent; evaluate functional impairment
• Screen for other seizure types: Adults with absence seizures often have coexisting generalized tonic-clonic seizures (70% response to treatment) or myoclonic jerks (75% response) 2

Diagnostic Testing

• EEG is essential: Obtain electroencephalography to confirm 3-4 Hz generalized spike-wave discharges 3
• Hyperventilation during EEG: Precipitates absences in ~90% of untreated patients, confirming diagnosis 2
• Neuroimaging recommended: MRI is preferred for adults presenting with first seizure to exclude structural causes 3
• Laboratory evaluation: Check sodium and glucose levels as most common abnormalities associated with seizures 3

Important Caveat on Self-Reporting

Adults with absence seizures frequently misreport their seizure frequency—66.7% provide inaccurate counts, with 37.5% overestimating and 29.2% underestimating 4. Consider video-EEG monitoring if treatment decisions hinge on accurate seizure counts.

First-Line Treatment Options

Valproic Acid (Preferred for Most Adults)

• Efficacy: Controls absences in 75% of patients
• Additional benefit: Also treats GTCS (70%) and myoclonic jerks (75%) that commonly coexist 2
• Major contraindication: Avoid in women of childbearing potential due to teratogenicity 1

Ethosuximide

• Efficacy: Controls 70% of absences 2
• Limitation: Only effective for absence seizures—unsuitable as monotherapy if other generalized seizures coexist 2
• Best for: Isolated absence seizures without GTCS or myoclonic jerks

Lamotrigine

• Efficacy: Controls absences and GTCS in 50-60% of patients 2
• Advantage: Safer option for women of childbearing potential 1
• Cautions: May worsen myoclonic jerks; skin rashes common (monitor closely during titration) 2

Treatment Algorithm

1. If absences are the only seizure type: Consider ethosuximide or lamotrigine
2. If other generalized seizures coexist (most common in adults): Start with valproic acid unless contraindicated
3. For women of childbearing potential: Use lamotrigine or ethosuximide, avoiding valproic acid 1

Management of Resistant Cases

Approximately 25% of patients have difficult-to-treat absences despite adequate medication 1. For these patients:

Combination Therapy

• Low-dose lamotrigine added to valproic acid: May produce dramatic beneficial effect 2
• Other combinations: Any combination of ethosuximide, valproic acid, or lamotrigine may be needed 1, 2

Alternative Medications

• Clonazepam: Particularly useful for absences with myoclonic components 2
• Levetiracetam, topiramate, or zonisamide: Consider as alternatives after excluding pseudo-drug resistance 1
• Newer options: Brivaracetam and perampanel show promise but require more evidence 1

Before Escalating Treatment

Rule out pseudo-drug resistance: Verify medication adherence, adequate dosing, and confirm diagnosis with video-EEG if self-reporting is unreliable 1, 4

Syndrome-Specific Considerations

Adults with absence seizures typically have idiopathic generalized epilepsy syndromes where absences may be:

• Predominant: Requiring aggressive treatment
• Mild and non-predominant: As in juvenile myoclonic epilepsy where myoclonic jerks and GTCS are the main concern 2

The syndromic diagnosis influences treatment strategy—identify the specific syndrome to optimize management and provide accurate prognosis 2.

Monitoring and Follow-up

• EEG monitoring: Useful for assessing treatment response, particularly with hyperventilation to provoke absences 5
• Functional assessment: Prioritize limiting cognitive side effects of medications, as evidence that seizure freedom improves cognitive deficits is weak 6
• Status epilepticus risk: Occurs in ~30% of patients with typical absences; educate patients on recognition 2